Virtus Fund Advisers’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$1M Buy
9,629
+8,805
+1,069% +$994K 0.01% 285
2017
Q3
$120K Hold
824
﹤0.01% 393
2017
Q2
$109K Hold
824
﹤0.01% 427
2017
Q1
$103K Hold
824
﹤0.01% 432
2016
Q4
$95K Hold
824
﹤0.01% 430
2016
Q3
$86K Hold
824
﹤0.01% 441
2016
Q2
$83K Hold
824
﹤0.01% 436
2016
Q1
$82K Hold
824
﹤0.01% 437
2015
Q4
$99K Hold
824
﹤0.01% 411
2015
Q3
$89K Hold
824
﹤0.01% 400
2015
Q2
$95K Hold
824
﹤0.01% 420
2015
Q1
$95K Sell
824
-924
-53% -$110K ﹤0.01% 540
2014
Q4
$196K Hold
1,748
﹤0.01% 436
2014
Q3
$166K Sell
1,748
-7,226
-81% -$652K ﹤0.01% 483
2014
Q2
$771K Buy
+8,974
New +$682K 0.01% 506

Other funds holding CELG

Virtus Fund Advisers's CELG Position: Q4 2017 in Review

Virtus Fund Advisers increased its Celgene Corp (CELG) stake by 1,069% in Q4 2017, buying an estimated $994K and bringing the position to 9,629 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #285.

Virtus Fund Advisers first reported a position in CELG in Q2 2014 and has held it in 15 quarters since. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Virtus Fund Advisers held 9,629 shares of Celgene Corp worth $1M as of Q4 2017.
  • Virtus Fund Advisers bought 8,805 Celgene Corp shares in Q4 2017, an estimated $994K.
  • Celgene Corp made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #285 holding.
  • Virtus Fund Advisers first reported a position in Celgene Corp in Q2 2014 and has held it in 15 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.